Not Tagged
coherus,spdr s&p biotech
['$chrs', '$xbi']
$xbi #asco23 the best part about brad's interviews: not having to wait for an hour on cnbc to hear 5 min of curated content (esp after meg left) this is a particularly great interview with $chrs ceo, where brad asks the tough questions that many investors are struggling with, 
Biotech investing. May have positions related to tweets. Opinions and tweets are not investment advice